December 9, 2024 - 18:13

Shares of CE Info Systems Ltd., widely recognized as MapmyIndia, experienced a significant increase after the company announced it would not proceed with its previously proposed plan to separate its consumer business. This decision has been met with a positive response from investors, reflecting confidence in the company's integrated approach to its services.
The initial plan to split the consumer segment from its core business raised concerns among stakeholders about potential disruptions and the future direction of the company. However, by scrapping this idea, MapmyIndia aims to consolidate its resources and maintain a unified strategy that leverages its strengths in mapping and location-based services.
Market analysts suggest that this move could enhance operational efficiency and drive growth, as the company continues to innovate and expand its offerings. The surge in shares signals strong investor sentiment, indicating optimism for the company's future performance in the competitive mapping and navigation industry.
November 13, 2026 - 22:40
SuperQ Quantum Expands European Presence with Trade Mission in Spain and Upcoming Festival in CannesCalgary, Alberta - SuperQ Quantum Computing Inc. is making significant strides in its European business development. Recently, the company participated in a trade mission in Barcelona, Spain, which...
November 13, 2026 - 06:15
Singtel CEO Addresses Data Center Resilience Amid Nvidia DevelopmentsSingtel Group CEO Yuen Kuan Moon has stated that the recent news surrounding Nvidia will have a limited effect on the company`s data center operations. While Singtel does utilize Nvidia`s GPUs,...
November 12, 2026 - 23:59
Hawaiʻi Takes Action to Enhance Business Registration and Reduce DelaysThe Hawaiʻi Department of Commerce and Consumer Affairs has announced a series of initiatives aimed at improving the state`s business registration system. This move comes in response to growing...
November 12, 2026 - 05:45
Financial Backers Hesitant About Gene Therapy's ViabilityInvestors are increasingly cautious about the future of gene therapy, a groundbreaking approach to treating genetic disorders. Unlike traditional pharmaceuticals, which benefit from mass production...